等待開盤 09-20 09:30:00 美东时间
0.000
0.00%
CAMBRIDGE, Mass., Sept. 10, 2024 /PRNewswire/ -- Blueprint Medicines Corporatio...
09-10 20:01
Piper Sandler analysts put out a list of companies that show three weeks of deteriorating technical grade rankings within their universe of coverage. Within energy (XLE): Core Laboratories Inc. (CLB) ...
08-20 23:27
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu,...
08-16 18:38
Baird analyst Joel Beatty maintains Blueprint Medicines (NASDAQ:BPMC) with a Outperform and raises the price target from $112 to $127.
08-02 22:44
Goldman Sachs analyst Salveen Richter has maintained their bullish stance on BP...
08-02 05:25
Blueprint Medicines (NASDAQ:BPMC) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.30) by 38.46 percent. The company reported quarterly sales of $138.157 million which beat
08-01 19:09
In the latest quarter, 15 analysts provided ratings for Blueprint Medicines (NA...
07-30 03:00
We feel now is a pretty good time to analyse Blueprint Medicines Corporation's ...
07-24 00:39
SMID-cap growth stocks (NYSEARCA:IWO) strike an attractive balance between secular growth leadership and intermediate-term rotation potential, said Oppenheimer analysts in a Technical Analysis note. A...
07-16 02:00
Oppenheimer research analysts outlined the top small-cap and mid-cap stocks that have exposure to several high-growth themes. These stocks are high-conviction “SMID-cap” ideas for 2024 with a market c...
07-11 00:46